Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Imperial Innovations Group (IVO) Regulatory News

Date Source Headline
20th Sep 2013 9:00 am RNS Notice of Results
12th Sep 2013 7:00 am RNS Circassia phase II clinical study success
10th Sep 2013 7:00 am RNS Leads £8m funding round in Plaxica
29th Aug 2013 7:00 am RNS Investment in new mobile payments business
12th Aug 2013 6:01 pm RNS Director/PDMR Shareholding
26th Jul 2013 8:45 am RNS Portfolio company PolyTherics merges with Antitope
17th Jul 2013 7:00 am RNS Directorate Change
2nd Jul 2013 7:00 am RNS £30m loan from EIB for healthcare investment
25th Jun 2013 7:00 am RNS Investment in PsychologyOnline
4th Jun 2013 7:00 am RNS Autifony starts phase I trial
8th May 2013 7:00 am RNS Cell Medica treats first patient in new trial
29th Apr 2013 7:00 am RNS Investment team appointment
17th Apr 2013 9:26 am RNS Board change
22nd Mar 2013 7:00 am RNS Half year results
1st Mar 2013 9:22 am RNS Notice of Results
1st Mar 2013 8:38 am RNS Notification of major interest in shares
25th Feb 2013 7:00 am RNS Circassia's cat allergy treatment
14th Feb 2013 7:00 am RNS Investment in new technology company
23rd Jan 2013 7:00 am RNS £1.5m investment in new software portfolio company
21st Jan 2013 3:45 pm RNS Listing of shares
12th Dec 2012 3:02 pm RNS Result of AGM
16th Nov 2012 7:00 am RNS Veryan CE Mark approval for BioMimics 3D Stent
5th Nov 2012 7:00 am RNS Portfolio companies receive government funding
19th Oct 2012 10:00 am RNS Grant of share options
5th Oct 2012 7:00 am RNS Full year results
4th Oct 2012 7:00 am RNS Circassia initiates phase III trial
26th Sep 2012 7:00 am RNS PsiOxus commences clinical trial
20th Sep 2012 12:39 pm RNS Notice of Results
13th Sep 2012 3:25 pm RNS Circassia appoints Dr Brett Haumann as CMO
12th Sep 2012 11:35 am RNS Award Win
6th Sep 2012 7:00 am RNS Investment in Cambridge technology company
1st Aug 2012 3:58 pm RNS Director Dealings
23rd Jul 2012 7:00 am RNS Investment in portfolio company
11th Jul 2012 2:50 pm RNS Veryan Medical appoints new COO and NEDs
9th Jul 2012 7:00 am RNS £22m funding round for PsiOxus Therapeutics
5th Jul 2012 5:20 pm RNS Grant of share options
27th Jun 2012 8:12 am RNS Abingdon Health acquires controlling stake
18th Jun 2012 7:00 am RNS Investment in Oxford healthcare company
12th Jun 2012 7:00 am RNS Investment in Cambridge technology company
31st May 2012 9:36 am RNS Director/PDMR Shareholding
FTSE 100 Latest
Value8,275.66
Change0.00